Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- Check7 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA site-wide notice announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now shows a 403 Forbidden error, and multiple documents such as the SAP and Study Protocol were removed, affecting access to essential trial materials.SummaryDifference17%

- Check70 days agoChange DetectedThe revision label changes from v3.6.5 to v3.6.6. This reflects a minor version update to the page or its underlying components.SummaryDifference0.0%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.